[HTML][HTML] A look into the future: Are we ready for an approved therapy in celiac disease?
RP Anderson, R Verma, M Schumann - Gastroenterology, 2024 - Elsevier
As it appears that we are currently at the cusp of an era in which drugs that are new, re-
purposed, or “supplements” will be introduced to the management of celiac disease, we …
purposed, or “supplements” will be introduced to the management of celiac disease, we …
Nutrition assessment and management in celiac disease.
CeD is the most common immune condition affecting the gastrointestinal tract; it is triggered
by gluten and the only available treatment is a strict gluten-free diet (GFD). Therefore, for …
by gluten and the only available treatment is a strict gluten-free diet (GFD). Therefore, for …
[HTML][HTML] Advances in nonresponsive and refractory celiac disease
G Malamut, CR Soderquist, G Bhagat… - Gastroenterology, 2024 - Elsevier
Nonresponsive celiac disease (CeD) is relatively common. It is generally attributed to
persistent gluten exposure and resolves after correction of diet errors. However, other …
persistent gluten exposure and resolves after correction of diet errors. However, other …
[HTML][HTML] Exploring factors influencing quality of life variability among individuals with coeliac disease: an online survey
M Elwenspoek, J Banks, PP Desale… - BMJ Open …, 2024 - bmjopengastro.bmj.com
Objective Patients with coeliac disease (CD) need to follow a strict gluten-free diet to
manage symptoms and prevent complications. Restrictions imposed by the diet can be …
manage symptoms and prevent complications. Restrictions imposed by the diet can be …
Who gets an annual review for coeliac disease? Patients with lower health literacy and lower dietary adherence consider them important
YM Jeanes, S Kallos, H Muhammad… - Journal of Human …, 2024 - Wiley Online Library
Background A lifelong gluten‐free (GF) diet to manage coeliac disease is recognised to be
challenging. This paper comprises two studies: study one aimed to report the opinions of …
challenging. This paper comprises two studies: study one aimed to report the opinions of …
Comparative Performance of Stool Gluten Immunogenic Peptide Platforms for Monitoring Adherence to the Gluten-Free Diet
JP Stefanolo, R Puebla, M Talamo, S Dodds… - 2024 - preprints.org
Background/Aim: Stool gluten immunogenic peptides (GIP) determination is now considered
a valuable tool for detecting dietary lapses in treated celiac disease (CeD) patients. Our …
a valuable tool for detecting dietary lapses in treated celiac disease (CeD) patients. Our …
[PDF][PDF] Celiachia: il problema è il glutine
IL TEMA, ALLE L'INTERVISTA, LA SCHEDA - pacinimedicina.it
OPEN ACCESS La rivista è open access e divulgata sulla base della licenza CC-BY-NC-ND
(Creative Commons Attribuzione–Non commerciale–Non opere derivate 4.0 Internazionale) …
(Creative Commons Attribuzione–Non commerciale–Non opere derivate 4.0 Internazionale) …